{"id":20939,"date":"2025-03-21T05:28:40","date_gmt":"2025-03-21T05:28:40","guid":{"rendered":"https:\/\/www.ttci-th.org\/?p=20939"},"modified":"2026-03-18T01:15:12","modified_gmt":"2026-03-18T01:15:12","slug":"cd70-car-t-dual-antibody","status":"publish","type":"post","link":"https:\/\/www.ttci-th.org\/th\/cd70-car-t-dual-antibody\/","title":{"rendered":"CD70 CAR T cells secreting an anti-CD33\/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML"},"content":{"rendered":"You must be logged in to view this content.","protected":false},"excerpt":{"rendered":"You must be logged in to view this content.","protected":false},"author":4,"featured_media":20941,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[182],"tags":[],"class_list":["post-20939","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-members"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.1.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"This resource is exclusive to registered members of the Thailand Hub of Talents in Cancer Immunotherapy (TTCI). Login Instructions: Please use your officially assigned Member ID as both your Username and Password. Need Assistance? If you have not received your login credentials or are experiencing issues signing in, please contact the TTCI Secretariat at: info.ttci.th@gmail.com\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"admin@narisara\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.ttci-th.org\/th\/cd70-car-t-dual-antibody\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.1.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"th_TH\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand) - TTCI-TH\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"CD70 CAR T cells secreting an anti-CD33\/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML - Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand)\" \/>\n\t\t<meta property=\"og:description\" content=\"This resource is exclusive to registered members of the Thailand Hub of Talents in Cancer Immunotherapy (TTCI). Login Instructions: Please use your officially assigned Member ID as both your Username and Password. Need Assistance? If you have not received your login credentials or are experiencing issues signing in, please contact the TTCI Secretariat at: info.ttci.th@gmail.com\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.ttci-th.org\/th\/cd70-car-t-dual-antibody\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2025\/03\/2025-03-21.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2025\/03\/2025-03-21.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"2000\" \/>\n\t\t<meta property=\"og:image:height\" content=\"2000\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2025-03-21T05:28:40+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-03-18T01:15:12+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/web.facebook.com\/ttci.th\/\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:site\" content=\"@ttci_th\" \/>\n\t\t<meta name=\"twitter:title\" content=\"CD70 CAR T cells secreting an anti-CD33\/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML - Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand)\" \/>\n\t\t<meta name=\"twitter:description\" content=\"This resource is exclusive to registered members of the Thailand Hub of Talents in Cancer Immunotherapy (TTCI). Login Instructions: Please use your officially assigned Member ID as both your Username and Password. Need Assistance? If you have not received your login credentials or are experiencing issues signing in, please contact the TTCI Secretariat at: info.ttci.th@gmail.com\" \/>\n\t\t<meta name=\"twitter:creator\" content=\"@ttci_th\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2025\/03\/2025-03-21.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/cd70-car-t-dual-antibody\\\/#blogposting\",\"name\":\"CD70 CAR T cells secreting an anti-CD33\\\/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML - Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand)\",\"headline\":\"CD70 CAR T cells secreting an anti-CD33\\\/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML\",\"author\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/author\\\/adminnarisara\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/2025-03-21.png\",\"width\":2000,\"height\":2000},\"datePublished\":\"2025-03-21T05:28:40+00:00\",\"dateModified\":\"2026-03-18T01:15:12+00:00\",\"inLanguage\":\"th\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/cd70-car-t-dual-antibody\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/cd70-car-t-dual-antibody\\\/#webpage\"},\"articleSection\":\"Member Content\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/cd70-car-t-dual-antibody\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.ttci-th.org\\\/th\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/members\\\/#listItem\",\"name\":\"Member Content\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/members\\\/#listItem\",\"position\":2,\"name\":\"Member Content\",\"item\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/members\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/cd70-car-t-dual-antibody\\\/#listItem\",\"name\":\"CD70 CAR T cells secreting an anti-CD33\\\/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/cd70-car-t-dual-antibody\\\/#listItem\",\"position\":3,\"name\":\"CD70 CAR T cells secreting an anti-CD33\\\/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/category\\\/members\\\/#listItem\",\"name\":\"Member Content\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#organization\",\"name\":\"Thailand Hub of Talents in Cancer Immunotherapy\",\"description\":\"TTCI-TH\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/wp-content\\\/uploads\\\/2023\\\/05\\\/cropped-cropped-TTCI_LOGO__PNG_-001-removebg-preview.png\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/cd70-car-t-dual-antibody\\\/#organizationLogo\",\"width\":512,\"height\":512},\"image\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/cd70-car-t-dual-antibody\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/web.facebook.com\\\/ttci.th\\\/\",\"https:\\\/\\\/www.twitter.com\\\/ttci_th\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/author\\\/adminnarisara\\\/#author\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/author\\\/adminnarisara\\\/\",\"name\":\"admin@narisara\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/cd70-car-t-dual-antibody\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/75b4fa1780d4337192829073b76451e4e65b3d665abf974c24531ee7367104a4?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"admin@narisara\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/cd70-car-t-dual-antibody\\\/#webpage\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/cd70-car-t-dual-antibody\\\/\",\"name\":\"CD70 CAR T cells secreting an anti-CD33\\\/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML - Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand)\",\"description\":\"This resource is exclusive to registered members of the Thailand Hub of Talents in Cancer Immunotherapy (TTCI). Login Instructions: Please use your officially assigned Member ID as both your Username and Password. Need Assistance? If you have not received your login credentials or are experiencing issues signing in, please contact the TTCI Secretariat at: info.ttci.th@gmail.com\",\"inLanguage\":\"th\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/cd70-car-t-dual-antibody\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/author\\\/adminnarisara\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/author\\\/adminnarisara\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/wp-content\\\/uploads\\\/2025\\\/03\\\/2025-03-21.png\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/cd70-car-t-dual-antibody\\\/#mainImage\",\"width\":2000,\"height\":2000},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/cd70-car-t-dual-antibody\\\/#mainImage\"},\"datePublished\":\"2025-03-21T05:28:40+00:00\",\"dateModified\":\"2026-03-18T01:15:12+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#website\",\"url\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/\",\"name\":\"Thailand Hub of Talents in Cancer Immunotherapy\",\"description\":\"TTCI-TH\",\"inLanguage\":\"th\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.ttci-th.org\\\/th\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"CD70 CAR T cells secreting an anti-CD33\/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML - Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand)","description":"This resource is exclusive to registered members of the Thailand Hub of Talents in Cancer Immunotherapy (TTCI). Login Instructions: Please use your officially assigned Member ID as both your Username and Password. Need Assistance? If you have not received your login credentials or are experiencing issues signing in, please contact the TTCI Secretariat at: info.ttci.th@gmail.com","canonical_url":"https:\/\/www.ttci-th.org\/th\/cd70-car-t-dual-antibody\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/www.ttci-th.org\/th\/cd70-car-t-dual-antibody\/#blogposting","name":"CD70 CAR T cells secreting an anti-CD33\/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML - Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand)","headline":"CD70 CAR T cells secreting an anti-CD33\/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML","author":{"@id":"https:\/\/www.ttci-th.org\/th\/author\/adminnarisara\/#author"},"publisher":{"@id":"https:\/\/www.ttci-th.org\/th\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2025\/03\/2025-03-21.png","width":2000,"height":2000},"datePublished":"2025-03-21T05:28:40+00:00","dateModified":"2026-03-18T01:15:12+00:00","inLanguage":"th","mainEntityOfPage":{"@id":"https:\/\/www.ttci-th.org\/th\/cd70-car-t-dual-antibody\/#webpage"},"isPartOf":{"@id":"https:\/\/www.ttci-th.org\/th\/cd70-car-t-dual-antibody\/#webpage"},"articleSection":"Member Content"},{"@type":"BreadcrumbList","@id":"https:\/\/www.ttci-th.org\/th\/cd70-car-t-dual-antibody\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th#listItem","position":1,"name":"Home","item":"https:\/\/www.ttci-th.org\/th","nextItem":{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/category\/members\/#listItem","name":"Member Content"}},{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/category\/members\/#listItem","position":2,"name":"Member Content","item":"https:\/\/www.ttci-th.org\/th\/category\/members\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/cd70-car-t-dual-antibody\/#listItem","name":"CD70 CAR T cells secreting an anti-CD33\/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/cd70-car-t-dual-antibody\/#listItem","position":3,"name":"CD70 CAR T cells secreting an anti-CD33\/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML","previousItem":{"@type":"ListItem","@id":"https:\/\/www.ttci-th.org\/th\/category\/members\/#listItem","name":"Member Content"}}]},{"@type":"Organization","@id":"https:\/\/www.ttci-th.org\/th\/#organization","name":"Thailand Hub of Talents in Cancer Immunotherapy","description":"TTCI-TH","url":"https:\/\/www.ttci-th.org\/th\/","logo":{"@type":"ImageObject","url":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2023\/05\/cropped-cropped-TTCI_LOGO__PNG_-001-removebg-preview.png","@id":"https:\/\/www.ttci-th.org\/th\/cd70-car-t-dual-antibody\/#organizationLogo","width":512,"height":512},"image":{"@id":"https:\/\/www.ttci-th.org\/th\/cd70-car-t-dual-antibody\/#organizationLogo"},"sameAs":["https:\/\/web.facebook.com\/ttci.th\/","https:\/\/www.twitter.com\/ttci_th\/"]},{"@type":"Person","@id":"https:\/\/www.ttci-th.org\/th\/author\/adminnarisara\/#author","url":"https:\/\/www.ttci-th.org\/th\/author\/adminnarisara\/","name":"admin@narisara","image":{"@type":"ImageObject","@id":"https:\/\/www.ttci-th.org\/th\/cd70-car-t-dual-antibody\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/75b4fa1780d4337192829073b76451e4e65b3d665abf974c24531ee7367104a4?s=96&d=mm&r=g","width":96,"height":96,"caption":"admin@narisara"}},{"@type":"WebPage","@id":"https:\/\/www.ttci-th.org\/th\/cd70-car-t-dual-antibody\/#webpage","url":"https:\/\/www.ttci-th.org\/th\/cd70-car-t-dual-antibody\/","name":"CD70 CAR T cells secreting an anti-CD33\/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML - Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand)","description":"This resource is exclusive to registered members of the Thailand Hub of Talents in Cancer Immunotherapy (TTCI). Login Instructions: Please use your officially assigned Member ID as both your Username and Password. Need Assistance? If you have not received your login credentials or are experiencing issues signing in, please contact the TTCI Secretariat at: info.ttci.th@gmail.com","inLanguage":"th","isPartOf":{"@id":"https:\/\/www.ttci-th.org\/th\/#website"},"breadcrumb":{"@id":"https:\/\/www.ttci-th.org\/th\/cd70-car-t-dual-antibody\/#breadcrumblist"},"author":{"@id":"https:\/\/www.ttci-th.org\/th\/author\/adminnarisara\/#author"},"creator":{"@id":"https:\/\/www.ttci-th.org\/th\/author\/adminnarisara\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2025\/03\/2025-03-21.png","@id":"https:\/\/www.ttci-th.org\/th\/cd70-car-t-dual-antibody\/#mainImage","width":2000,"height":2000},"primaryImageOfPage":{"@id":"https:\/\/www.ttci-th.org\/th\/cd70-car-t-dual-antibody\/#mainImage"},"datePublished":"2025-03-21T05:28:40+00:00","dateModified":"2026-03-18T01:15:12+00:00"},{"@type":"WebSite","@id":"https:\/\/www.ttci-th.org\/th\/#website","url":"https:\/\/www.ttci-th.org\/th\/","name":"Thailand Hub of Talents in Cancer Immunotherapy","description":"TTCI-TH","inLanguage":"th","publisher":{"@id":"https:\/\/www.ttci-th.org\/th\/#organization"}}]},"og:locale":"th_TH","og:site_name":"Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand) - TTCI-TH","og:type":"article","og:title":"CD70 CAR T cells secreting an anti-CD33\/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML - Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand)","og:description":"This resource is exclusive to registered members of the Thailand Hub of Talents in Cancer Immunotherapy (TTCI). Login Instructions: Please use your officially assigned Member ID as both your Username and Password. Need Assistance? If you have not received your login credentials or are experiencing issues signing in, please contact the TTCI Secretariat at: info.ttci.th@gmail.com","og:url":"https:\/\/www.ttci-th.org\/th\/cd70-car-t-dual-antibody\/","og:image":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2025\/03\/2025-03-21.png","og:image:secure_url":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2025\/03\/2025-03-21.png","og:image:width":"2000","og:image:height":"2000","article:published_time":"2025-03-21T05:28:40+00:00","article:modified_time":"2026-03-18T01:15:12+00:00","article:publisher":"https:\/\/web.facebook.com\/ttci.th\/","twitter:card":"summary_large_image","twitter:site":"@ttci_th","twitter:title":"CD70 CAR T cells secreting an anti-CD33\/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML - Thailand Hub of Talents in Cancer Immunotherapy (TTCI Thailand)","twitter:description":"This resource is exclusive to registered members of the Thailand Hub of Talents in Cancer Immunotherapy (TTCI). Login Instructions: Please use your officially assigned Member ID as both your Username and Password. Need Assistance? If you have not received your login credentials or are experiencing issues signing in, please contact the TTCI Secretariat at: info.ttci.th@gmail.com","twitter:creator":"@ttci_th","twitter:image":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2025\/03\/2025-03-21.png"},"aioseo_meta_data":{"post_id":"20939","title":null,"description":null,"keywords":[],"keyphrases":{"focus":{"keyphrase":"antibody ","score":58,"analysis":{"keyphraseInTitle":{"score":9,"maxScore":9,"error":0},"keyphraseInDescription":{"score":3,"maxScore":9,"error":1},"keyphraseLength":{"score":9,"maxScore":9,"error":0,"length":1},"keyphraseInURL":{"score":5,"maxScore":5,"error":0},"keyphraseInIntroduction":{"score":3,"maxScore":9,"error":1},"keyphraseInSubHeadings":[],"keyphraseInImageAlt":[],"keywordDensity":{"score":0,"type":"low","maxScore":9,"error":1}}},"additional":[]},"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"featured","og_image_url":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2025\/03\/2025-03-21.png","og_image_width":"2000","og_image_height":"2000","og_image_custom_url":null,"og_image_custom_fields":null,"og_video":"","og_custom_url":null,"og_article_section":null,"og_article_tags":[],"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"featured","twitter_image_url":"https:\/\/www.ttci-th.org\/wp-content\/uploads\/2025\/03\/2025-03-21.png","twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"BlogPosting","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":"-1","robots_max_videopreview":"-1","robots_max_imagepreview":"large","priority":null,"frequency":"default","local_seo":null,"limit_modified_date":false,"created":"2025-03-23 05:34:50","updated":"2026-09-03 07:15:37","focus_keyword":"antibody","additional_keywords":null,"truseo_locale":null,"ai":null,"breadcrumb_settings":null,"seo_analyzer_scan_date":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.ttci-th.org\/th\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.ttci-th.org\/th\/category\/members\/\" title=\"Member Content\">Member Content<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">&raquo;<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tCD70 CAR T cells secreting an anti-CD33\/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.ttci-th.org\/th"},{"label":"Member Content","link":"https:\/\/www.ttci-th.org\/th\/category\/members\/"},{"label":"CD70 CAR T cells secreting an anti-CD33\/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML","link":"https:\/\/www.ttci-th.org\/th\/cd70-car-t-dual-antibody\/"}],"_links":{"self":[{"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/posts\/20939","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/comments?post=20939"}],"version-history":[{"count":0,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/posts\/20939\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/media\/20941"}],"wp:attachment":[{"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/media?parent=20939"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/categories?post=20939"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ttci-th.org\/th\/wp-json\/wp\/v2\/tags?post=20939"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}